Health News

New Recommendations for Hemophilia Patients
The National Hemophilia Foundation (NHF) recently issued a new recommendation on inhibitor testing for patients with hemophilia A and B.
New Multiple Myeloma Rx Gets Go-Ahead
A new FDA approval could give another option to multiple myeloma patients who haven't had luck with past treatments. {C}
Ninlaro Approved for Multiple Myeloma
Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.
An Extra Benefit for Sickle Cell Rx
A drug commonly used to treat sickle cell disease (SCD) may wind up helping patients in more ways than one.
A Shot Against Multiple Myeloma
For multiple myeloma patients who haven't responded to past treatments, a newly approved medication could provide hope.
New Rx for Multiple Myeloma
Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments.
Modified Hemophilia Rx Approved
The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A.
Leukemia FAQ
Leukemia is a cancer of the blood cells that most commonly occurs in adults older than 55 and is also the most common cancer in children younger than 15. There are currently more than 300,000 people estimated to be living with or in remission from leukemia in the US. 
FDA OKs Hyperkalemia Rx
A new medication could help patients with a serious condition called hyperkalemia.
Hereditary Bleeding Disorder Rx Approved
The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency.